Form 8-K - Current report:
SEC Accession No. 0001823239-22-000008
Filing Date
2022-02-23
Accepted
2022-02-23 16:08:13
Documents
13
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20220223.htm   iXBRL 8-K 40448
2 EX-99.1 exhibit991-q42021.htm EX-99.1 189349
  Complete submission text file 0001823239-22-000008.txt   388876

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20220223.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20220223_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20220223_pre.xml EX-101.PRE 13044
7 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20220223_htm.xml XML 12168
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 22663581
SIC: 2834 Pharmaceutical Preparations